Ann: Section 708A Notice and Appendix 2A, page-24

These latest evaluation announcements is telling the market that there's still doubt for such a disruptive respiratory medical device since the stethoscope so, IMO, most are seeing how the technology perform on Coviu and Phenix platform and then BOOM.....but I also thought at least a few more telehealth providers or clinics would have signed up by now and taken the "leap of faith" like Coviu and Phenix....maybe tomorrow???